Enhanced production of fibrinolytic enzyme by a new Xanthomonas oryzae IND3 using low-cost culture medium by response surface methodology

Cardiovascular diseases (CVDs) cause high mortality throughout the world. Existing fibrinolytic agents are highly expensive and have many side effects. Microbial fibrinolytic enzymes are very much considered as novel therapeutic candidate for the treatment of CVDs. Reports on fibrinolytic enzyme fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijayaraghavan, Ponnuswamy, Arasu, Mariadhas Valan, Anantha Rajan, R., Al-Dhabi, N.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717107/
https://www.ncbi.nlm.nih.gov/pubmed/31485157
http://dx.doi.org/10.1016/j.sjbs.2018.08.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717107/
https://www.ncbi.nlm.nih.gov/pubmed/31485157
http://dx.doi.org/10.1016/j.sjbs.2018.08.029

Ejemplares similares